Healx receives US Orphan Drug Designation for its AI-discovered treatment of Neurofibromatosis Type 1 (NF1)
Cambridge, UK – 06 September 2023, 12:00 BST. Healx, the AI-powered, patient-inspired, techbio company pioneering the next generation of drug discovery has received Orphan Drug Designation from the US Food and Drug Administration (FDA) for its AI-discovered treatment of Neurofibromatosis Type 1 (NF1). Their team of expert scientists and technologists discovered HLX-1502 as a potential treatment for […]
Lig3DLens: An open source ligand-based 3D virtual screening toolbox
Bill Tatsis, Matt Seddon, Dan Mason, Dan O’Donovan, Gio Cincilla, Azedine Zoufir and Nath Brown Why? A common computational task we perform in drug design involves exploring the chemical space around an ‘initial’ hit molecule. Several commercial packages, like OpenEye, Cresset, and Schrödinger, are available for this purpose. Recently, an open-source alternative called VSFlow [1] […]